U.S. District Judge John Gleeson is overseeing a mounting caseload against pharmaceutical titan, Merck – maker of the popular hair loss drug, Propecia. According to court dockets, more than 1,100 product liability complaints alleging serious sexual side effects are pending against Merck in federal and state courts throughout the country.... Read more »

The European Medicines Agency recently released a statement regarding testosterone drug risks for patients using drugs like Androgel, Axiron, AndroDerm and Testim. The November 21 statement noted that drugs should be used with caution, although researchers are still working to determine their link to health problems. The statement was released... Read more »

The drug Actos has been on the market since 1999, and was once one of the highest-grossing type 2 diabetes drugs available. Developed by drug maker Takeda Pharmaceuticals, Actos is becoming increasingly linked with the onset of deadly bladder cancer – and plaintiffs across the United States are accusing Takeda... Read more »

Cholesterol-lowering statins are among world’s most widely prescribed drugs, but concerns about Lipitor side effects, including the increased risk for Type 2 diabetes, has fueled a wave of litigation and further research on safer alternatives. As reported by the New York Times, a new study has found another type of... Read more »

A recent study warns of the link between talcum powder cosmetic products and mesothelioma ─ a lethal form of lung cancer caused by exposure to asbestos. Talcum powder is used by a wide-variety of people, as it is commonly marketed as a post-shower body powder or a baby powder. U.S.... Read more »

Japan-based pharmaceutical giant Takeda currently faces more than 8,000 Actos lawsuits that accuse the company of concealing bladder cancer risks. Most of these complaints have been coordinated in Louisiana federal court, as a part of multidistrict litigation, where a landmark Actos lawsuit award was rendered in the case of Terrence... Read more »

A new order permitting the direct filing of testosterone lawsuits into federal multidistrict litigation (MDL) has been issued by U.S. District Judge Matthew Kennelly, in the Northern District of Illinois. Judge Kennelly has been appointed to oversee the MDL ─ established in June 2014 ─ which includes lawsuits from plaintiffs... Read more »

A motion to establish a multidistrict litigation (MDL) encompassing a growing number of Xarelto bleeding injury lawsuits will be heard on December 4 before the U.S. Judicial Panel on Multidistrict Litigation. The judges who are part of the panel will consider the merits of forming the MDL as a response... Read more »

Plaintiffs across the country have filed at least 21 Xarelto lawsuits against the maker of the popular blood thinner. The product liability lawsuits have been filed in 10 separate federal district courts. A group of the federal plaintiffs have now filed a motion for transfer requesting that the U.S. Judicial... Read more »

The drug Januvia is a widely-popular diabetes treatment option known as an “incretin mimetic.” The drug is manufactured by pharmaceutical giant Merck Sharp & Dohme, Corp. (hereinafter, “Merck”) and is one of the top-selling diabetes medications to date. However, an increasing number of Januvia users are reporting the sudden and... Read more »